登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 3986 条符合本次的查询结果， 用时 1.4005618 秒

3681. Subclavian Artery Branch Pseudoaneurysm Rupture With Massive Hemothorax in a Patient With Neurofibromatosis Type 1.

作者: Katherine E Negreira.;John P Lichtenberger.;Blair Allais.;Ammar Alhaddad.;Matthew Bernetich.;Vivek Jain.
来源: Chest. 2020年157卷4期e103-e105页
Neurofibromatosis type 1 is a rare disorder that occurs secondary to pathogenic variants in the NF1 tumor suppressor gene on chromosome 17. Characteristic clinical manifestations include multiple hyperpigmented macules, axillary and inguinal freckling, optic gliomas, and numerous skin neurofibromas. Vasculopathies are a rare complication of this disease and can affect vessels ranging from the proximal aorta to small arterioles, with pathology including arterial stenosis, aneurysms, and arteriovenous malformations. Aneurysms in these patients are often asymptomatic, and most patients with this complication appear for treatment after vessel rupture. We describe a 33-year-old man with neurofibromatosis type 1 who presented with chest pain and was ultimately found to have a ruptured left subclavian artery branch pseudoaneurysm leading to a large hemothorax.

3682. Harnessing Murine Microbiome Models to Study Human Lung Microbiome.

作者: De Chang.;Lokesh Sharma.;Charles S Dela Cruz.
来源: Chest. 2020年157卷4期776-778页

3683. Turning the Tide on Unproven Cell-Based Interventions.

作者: Laertis Ikonomou.;Daniel J Weiss.
来源: Chest. 2020年157卷4期774-775页

3684. More to Add to E-Cigarette Regulations: Unified Approaches.

作者: Hua Cai.;Joe G N Garcia.;Chen Wang.
来源: Chest. 2020年157卷4期771-773页

3685. Rebuttal From Dr Maron.

作者: Bradley A Maron.
来源: Chest. 2020年157卷4期769-770页

3686. Rebuttal From Dr Frantz.

作者: Robert P Frantz.
来源: Chest. 2020年157卷4期768-769页

3687. COUNTERPOINT: Should the New Definition of PH Be the Clinical Practice Standard? No.

作者: Robert P Frantz.
来源: Chest. 2020年157卷4期766-768页

3688. POINT: Should the New Definition of PH Be the Clinical Practice Standard? Yes.

作者: Bradley A Maron.
来源: Chest. 2020年157卷4期764-766页

3689. Selexipag Use in Clinical Practice: Mind the Gap.

作者: R James White.;Daniel J Lachant.
来源: Chest. 2020年157卷4期761-763页

3690. Point-of-Care Lung Ultrasound in Neonatology: Ready or Not, Here It Comes!

作者: Iuri Corsini.;Niccolò Parri.;Carlo Dani.
来源: Chest. 2020年157卷4期759-760页

3691. Lung Transplantation: Evolving Criteria for Referral and Patient Selection.

作者: Alicia B Mitchell.;Allan R Glanville.
来源: Chest. 2020年157卷4期757-758页

3692. Vitamin D Deficiency in COPD: Biomarker, Treatable Trait, or Just a Common Comorbidity?

作者: Stephen Milne.;Don D Sin.
来源: Chest. 2020年157卷4期755-756页

3693. Cardiovascular Risk in COPD: Searching for a Culprit.

作者: Isabelle Vivodtzev.;François Maltais.
来源: Chest. 2020年157卷4期753-754页

3694. In the Name of Contrast-Induced Acute Kidney Injury….

作者: Karim Lakhal.;Vincent Robert-Edan.;Stephan Ehrmann.
来源: Chest. 2020年157卷4期751-752页

3695. Repurposing the COPD Assessment Test: Another Step Forward for Bronchiectasis.

作者: Pamela J McShane.;Timothy R Aksamit.
来源: Chest. 2020年157卷4期749-750页

3696. Response.

作者: Shahrokh Javaheri.;Francisco Campos-Rodriguez.;Miguel Angel Martinez-Garcia.
来源: Chest. 2020年157卷4期1047-1048页

3697. CPAP Treatment and Cardiovascular Prevention: An Alternate Study Design That Includes Excessively Sleepy Patients.

作者: Bhajan Singh.;Greg Maislin.;Brendan T Keenan.;Nigel McArdle.;Diego R Mazzotti.;Ulysses Magalang.;Allan I Pack.; .
来源: Chest. 2020年157卷4期1046-1047页

3698. Observational Data With Inhaled Corticosteroid/Long-Acting Beta-Agonist/Long-Acting Muscarinic Antagonist May Not Reflect Current Practice With Single Triple Inhalers.

作者: Brian Lipworth.;Rory Chan.;Chris RuiWen Kuo.
来源: Chest. 2020年157卷4期1045页

3699. Response.

作者: Samy Suissa.;Pierre Ernst.
来源: Chest. 2020年157卷4期1045-1046页

3700. Response.

作者: Vishal J Tolia.;Danielle N O'Hara.;Kazi I Ullah.;Sahar Ahmad.
来源: Chest. 2020年157卷4期1044-1045页
共有 3986 条符合本次的查询结果， 用时 1.4005618 秒